Vestal Point Capital’s Crescent Biopharma CBIO Stock Holding History

Vestal Point Capital’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.6M	Hold	1,500,000	–	–	0.77%	43
2025 Q4	$17.8M	Buy	+1,500,000	New	+$19.1M	0.6%	40

Other funds holding CBIO

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return